• Molecular NamePancuronium
  • SynonymBromure de pancuronium [inn-french]; Bromuro de pancuronio [inn-spanish]; Pancuronium bromide; Pancuronium dibromide
  • Weight572.875
  • Drugbank_IDDB01337
  • ACS_NO16974-53-1
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-2.12
  • pkaN/A
  • LogD (pH=7, predicted)-2.12
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.12
  • LogSw (predicted, AB/LogsW2.0)77.23
  • Sw (mg/ml) (predicted, ACD/Labs)43.12
  • No.of HBond Donors0
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds6
  • TPSA52.6
  • StatusFDA approved
  • AdministrationIntravenous
  • PharmacologyA muscle relaxant with various purposes. It is one of the drugs administered during a lethal injection in the United States.
  • Absorption_value0.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability0.0
  • Protein binding7.0
  • Volume of distribution (VD)0.26 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life2.3 h
  • ExcretionRenal and biliary
  • Urinary Excretion67
  • Clerance1.8 ml/min/kg
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)LD50=1 (iv)